Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. García (Bogota, Colombia), C. Celis-Preciado (Bogota, Colombia), M. Rodríguez (Bogota, Colombia), V. Avendaño (Bogota, Colombia), A. Cañas-Arboleda (Bogota, Colombia), P. Rodríguez (Bogota, Colombia), L. Galindo (Bogota, Colombia), A. Gonzalez (Bogota, Colombia). Blood eosinophil levels and exacerbations in a cohort of biomass and tobacco-related COPD patients at high altitude (2600 m). 1881

Member's Comments

No comment yet.

Related content which might interest you: Dexamethasone treatment for patients with COPD when they travel to high altitude Source: International Congress 2019 – Advances in chronic obstructive pulmonary disease and asthma Year: 2019 COPD and asthma patients: what can they expect of high altitude residences? Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases Year: 2006 Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Blood eosinophils and exacerbation rate in COPD patients over three years Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 High altitude stay reduces eosinophil load in airways in children with asthma Source: Annual Congress 2012 - Predicting and observing paediatric allergic disease Year: 2012 Blood eosinophil in smokers and mild and moderate COPD patients Source: International Congress 2017 – Latest insights into the management of chronic lung diseases Year: 2017 LATE-BREAKING ABSTRACT: Tiotropium efficacy and exacerbation risk in patients with different blood eosinophil levels Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Effect of indacaterol/glycopyrronium (IND/GLY) vs salmeterol/fluticasone (SFC) on moderate or severe COPD exacerbations and lung function based on baseline blood eosinophil counts: Results from the FLAME study Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Altitude related adverse health effects in lowlanders with COPD travelling to 3200m Source: International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems Year: 2016 Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017 The impact of high eosinophil count on hospitalizations in COPD patients Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD Source: Eur Respir J, 51 (5) 1800120; 10.1183/13993003.00120-2018 Year: 2018 Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Comparison of COPD patients with high and low symptoms from a real-world US survey Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 The relationship between blood eosinophils and bacterial load in COPD patients Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017 COPD: Plasma surfactant protein-D (SPD) concentration as a predictor of acute exacerbations (AE) probability Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Elevated blood neutrophil levels in GOLD 2017 COPD group D – results from the TIE-study Source: International Congress 2017 – Markers of COPD progression Year: 2017 Effects of a daytrip to high altitude (2500m) in pulmonary hypertension. Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021